293 related articles for article (PubMed ID: 24050259)
1. Advanced cardiovascular stent coated with nanofiber.
Oh B; Lee CH
Mol Pharm; 2013 Dec; 10(12):4432-42. PubMed ID: 24050259
[TBL] [Abstract][Full Text] [Related]
2. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.
Nakano K; Egashira K; Masuda S; Funakoshi K; Zhao G; Kimura S; Matoba T; Sueishi K; Endo Y; Kawashima Y; Hara K; Tsujimoto H; Tominaga R; Sunagawa K
JACC Cardiovasc Interv; 2009 Apr; 2(4):277-83. PubMed ID: 19463437
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
4. Biomimicking Robust Hydrogel for the Mesenchymal Stem Cell Carrier.
Oh B; Melchert RB; Lee CH
Pharm Res; 2015 Oct; 32(10):3213-27. PubMed ID: 25911596
[TBL] [Abstract][Full Text] [Related]
5. Electrospinning of linezolid loaded PLGA nanofibers: effect of solvents on its spinnability, drug delivery, mechanical properties, and antibacterial activities.
Eren Boncu T; Ozdemir N; Uskudar Guclu A
Drug Dev Ind Pharm; 2020 Jan; 46(1):109-121. PubMed ID: 31905297
[No Abstract] [Full Text] [Related]
6. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
Zamani M; Prabhakaran MP; Varshosaz J; Mhaisalkar PS; Ramakrishna S
Acta Biomater; 2016 Sep; 42():316-328. PubMed ID: 27397493
[TBL] [Abstract][Full Text] [Related]
7. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
[TBL] [Abstract][Full Text] [Related]
9. Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol.
Guo X; Zhang X; Ye L; Zhang Y; Ding R; Hao Y; Zhao Y; Zhang Z; Zhang Y
J Drug Target; 2014 Jun; 22(5):421-7. PubMed ID: 24417740
[TBL] [Abstract][Full Text] [Related]
10. Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents.
Indolfi L; Causa F; Giovino C; Ungaro F; Quaglia F; Netti PA
J Biomed Mater Res A; 2011 May; 97(2):201-11. PubMed ID: 21394898
[TBL] [Abstract][Full Text] [Related]
11. trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16-F10 cells: cytotoxicity and phototoxicity.
Gomes AJ; Espreafico EM; Tfouni E
Mol Pharm; 2013 Oct; 10(10):3544-54. PubMed ID: 23865934
[TBL] [Abstract][Full Text] [Related]
12. Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes.
Chen DW; Hsu YH; Liao JY; Liu SJ; Chen JK; Ueng SW
Int J Pharm; 2012 Jul; 430(1-2):335-41. PubMed ID: 22521880
[TBL] [Abstract][Full Text] [Related]
13. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
[TBL] [Abstract][Full Text] [Related]
14. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Lactidyl/Glycolidyl Ratio and Molecular Weight of Poly(D,L -Lactide-co-Glycolide) on the Tetracycline Entrapment and Release Kinetics of Drug-Loaded Nanofibers.
Yan N; Zhang X; Cai Q; Yang X; Zhou X; Wang B; Deng X
J Biomater Sci Polym Ed; 2012; 23(8):1005-19. PubMed ID: 21477461
[TBL] [Abstract][Full Text] [Related]
16. Stent coating by electrospinning with chitosan/poly-cyclodextrin based nanofibers loaded with simvastatin for restenosis prevention.
Kersani D; Mougin J; Lopez M; Degoutin S; Tabary N; Cazaux F; Janus L; Maton M; Chai F; Sobocinski J; Blanchemain N; Martel B
Eur J Pharm Biopharm; 2020 May; 150():156-167. PubMed ID: 32179100
[TBL] [Abstract][Full Text] [Related]
17. Delivery of natural polyphenols by polymeric nanoparticles improves the resistance of endothelial progenitor cells to oxidative stress.
Felice F; Zambito Y; Belardinelli E; D'Onofrio C; Fabiano A; Balbarini A; Di Stefano R
Eur J Pharm Sci; 2013 Nov; 50(3-4):393-9. PubMed ID: 23988846
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
19. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL
Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
